Chelsea Therapeutics (CHTP) Announces Phase II Study of CH-4051 in Rheumatoid Arthritis Misses Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. TREX
4. SPY
5. WFC
6. ERAS
7. BAC
8. SPRO
9. SPCX
10. TSCO

Go back to Chelsea Therapeutics (CHTP) Announces Phase II Study of CH-4051 in Rheumatoid Arthritis Misses Primary Endpoint